Search results
FIBRIPHEN™ LRT
Clotting method for quantitative determination of fibrinogen (Clauss method)
FVIII Inhibitor Plasma (2) Moderate (11-50 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIX Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVIII Inhibitor Plasma (3) strong (51-200 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVIII Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
ZYMUTEST FPA Antigen (Plus Controls)
Assay proposed for the measurement of FPA in research applications.
CRYOcheck Hex LA, frozen
CRYOcheck Hex LA is an integrated (screen and confirm) silica-based aPTT assay and intended for use on automated coagulation analyzers.
BIOPHEN Antithrombin LRT (anti-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
CRYOcheck Abnormal 2 Control, frozen
CRYO check ™ Abnormal 2 Control is recommended for use as abnormal controls for PT and aPTT assays. Contains strongly reduced levels of clotting factors II, VII, IX and X.
CRYOcheck Abnormal 1 Control, frozen
CRYO check ™ Abnormal 1 Control is recommended for use as abnormal controls for PT and aPTT assays. Contains reduced levels of clotting factors II, VII, IX and X.